Evidence map›Paper›PMID 33166951›Full record

ArticleFetal diagnosis and therapy2020

Surviving Lambs with Myelomeningocele Repaired in utero with Placental Mesenchymal Stromal Cells for 6 Months: A Pilot Study.

Kaeli Yamashiro, Laura A Galganski, Jamie Peyton, Kalie Haynes, Victoria Vicuna, Priyadarsini Kumar, Benjamin Keller, James Becker, Christopher Pivetti, Sarah Stokes and 4 more

Open access · greenAbstract read
In one paragraph

Article in Fetal diagnosis and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Dural substitutes for spina bifida repair: past, present, and future.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Kaeli YamashiroDepartment of Surgery, University of California-Davis, Sacramento, California, USA, kjyamashiro@ucdavis.edu.
Laura A GalganskiDepartment of Surgery, University of California-Davis, Sacramento, California, USA.
Jamie PeytonDepartment of Veterinary Medicine, University of California-Davis, Sacramento, California, USA.
Kalie HaynesDepartment of Veterinary Medicine, University of California-Davis, Sacramento, California, USA.
Victoria VicunaDepartment of Veterinary Medicine, University of California-Davis, Sacramento, California, USA.
Priyadarsini KumarDepartment of Surgery, University of California-Davis, Sacramento, California, USA.
Benjamin KellerDepartment of Surgery, University of California-Davis, Sacramento, California, USA.
James BeckerDepartment of Surgery, University of California-Davis, Sacramento, California, USA.
Christopher PivettiDepartment of Surgery, University of California-Davis, Sacramento, California, USA.
Sarah StokesDepartment of Surgery, University of California-Davis, Sacramento, California, USA.
Christina TheodorouDepartment of Surgery, University of California-Davis, Sacramento, California, USA.
Jordan JacksonDepartment of Surgery, University of California-Davis, Sacramento, California, USA.
Aijun WangDepartment of Surgery, University of California-Davis, Sacramento, California, USA.
Diana FarmerDepartment of Surgery, University of California-Davis, Sacramento, California, USA.
University of California, Davis · USShriners Hospitals for Children - Northern California · USUniversity of California System · US

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
Engineered Neuroprotective Stem-Cell Exosomes for In Utero Spina Bifida TherapyR01NS115860 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FARMER, DIANA LEE, WANG, AIJUN · 2020 to 2024
$2.5M
Fetal Tissue Engineering to Treat Spina Bifida Before BirthR01NS100761 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WANG, AIJUN · 2017 to 2021
$1.7M
Guinea pigs as a model of in utero stem cell therapy for spina bifidaR03HD091601 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WANG, AIJUN · 2017 to 2018
$157k
NCATS NIH HHS UL1 TR001860NICHD NIH HHS R03 HD091601NINDS NIH HHS R01 NS100761NINDS NIH HHS R01 NS115860
6 · The paper itself

Abstract

backgroundFetal repair of myelomeningocele (MMC) with placental mesenchymal stromal cells (PMSCs) rescues ambulation in the ovine model up to 48 h postnatally. Outcomes past 48 h are unknown as MMC lambs have not been survived past this timepoint.

objectiveWe aimed to survive lambs for 6 months following the fetal repair of MMC with PMSCs.

methodsFetal MMC lambs were repaired with PMSCs. Lambs received either no additional treatment or postnatal bracing and physical therapy (B/PT). Motor function was assessed with the sheep locomotor rating (SLR). Lambs with an SLR of 15 at birth were survived for 6 months or until a decline in SLR less than 15, whichever came first. All lambs underwent a perimortem MRI.

resultsThe lambs with no postnatal treatment (n = 2) had SLR declines to 7 and 13 at 29 and 65 days, respectively, and were euthanized. These lambs had a spinal angulation of 57° and 47°, respectively. The B/PT lamb (n = 1) survived for 6 months with a sustained SLR of 15 and a lumbar angulation of 42°.

conclusionPostnatal physical therapy and bracing counteracted the inherent morbidity of the absent paraspinal muscles in the ovine MMC model allowing for survival and maintenance of rescued motor function of the prenatally treated lamb up to 6 months.

Indexed as

MeningomyeloceleMesenchymal Stem CellsAnimalsFemaleFetusPilot ProjectsPlacentaPregnancySheepFetal myelomeningocele repairFetal surgeryPlacental mesenchymal stromal cells

Identifiers

PMID33166951
PMCPMC7746588
OpenAlexW3104154322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.